These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37975050)
1. Von Willebrand Factor as a Biomarker for Liver Disease - An Update. Elhence A; Shalimar J Clin Exp Hepatol; 2023; 13(6):1047-1060. PubMed ID: 37975050 [TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296 [TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A; Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193 [TBL] [Abstract][Full Text] [Related]
4. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death. Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1362-1373.e6. PubMed ID: 34256145 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis. Zou Z; Yan X; Li C; Li X; Ma X; Zhang C; Ju S; Tian J; Qi X BMJ Open; 2019 Aug; 9(8):e025656. PubMed ID: 31473610 [TBL] [Abstract][Full Text] [Related]
6. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test. Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398 [TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis. Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661 [TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197 [TBL] [Abstract][Full Text] [Related]
9. Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma. Pereyra D; Mandorfer M; Santol J; Gregory L; Koeditz C; Ortmayr G; Schuetz C; Rumpf B; Ammon D; Laengle J; Schwarz C; Jonas JP; Pinter M; Lindenlaub F; Tamandl D; Thiels C; Warner S; Smoot R; Truty M; Kendrick M; Nagorney D; Cleary S; Gruenberger T; Reiberger T; Starlinger P Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38896229 [TBL] [Abstract][Full Text] [Related]
10. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis. Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435 [TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911 [TBL] [Abstract][Full Text] [Related]
12. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure. Prasanna KS; Goel A; Amirtharaj GJ; Ramachandran A; Balasubramanian KA; Mackie I; Zachariah U; Sajith KG; Elias E; Eapen CE Indian J Gastroenterol; 2016 Nov; 35(6):432-440. PubMed ID: 27822882 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease. Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M Dig Liver Dis; 2022 Oct; 54(10):1376-1384. PubMed ID: 35871985 [TBL] [Abstract][Full Text] [Related]
14. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score. Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803 [TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C. Takaya H; Kawaratani H; Tsuji Y; Nakanishi K; Saikawa S; Sato S; Sawada Y; Kaji K; Okura Y; Shimozato N; Kitade M; Akahane T; Moriya K; Namisaki T; Mitoro A; Matsumoto M; Fukui H; Yoshiji H United European Gastroenterol J; 2018 Nov; 6(9):1401-1409. PubMed ID: 30386613 [TBL] [Abstract][Full Text] [Related]